NEUARTIGE VERBINDUNGEN

Patent europeic · EP3668853 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3668853
Numer da la dumonda
EP18752172
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-08-2018
Publitgà
24-06-2020
Concedì
29-09-2021
La protecziun finescha il pli tard
14-08-2038
Proxima taxa annuala scadenta
31-08-2026
Classas IPC
C07D 401/04 (2006.01)
A61K 31/4427 (2006.01)
A61K 31/4523 (2006.01)
A61K 31/497 (2006.01)
A61K 31/501 (2006.01)
A61K 31/506 (2006.01)
A61P 31/06 (2006.01)
Prioritad
EP 17382570 16.08.2017
Dumonda PCT
PCT/EP2018/072144 15.08.2018
Publicaziun PCT
WO2019/034701 21.02.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 16-12-2025

    Curregì

    Owner
    GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom → GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom, Bioversys AG, Technologiepark Basel, Hochbergerstrasse 60c, 4057 Basel

    Published in Swissreg on 16.12.2025

  2. 07-11-2025

    Adressa dal possessur midada

    Owner
    GlaxoSmithKline Intellectual Property Development, Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom, Bioversys AG, Technologiepark Basel, Hochbergerstrasse 60c, 4057 Basel → GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom

    Published in Swissreg on 07.11.2025

  3. 01-09-2025

    Midada

    Published in Swissreg on 01.09.2025

  4. 01-09-2024

    Midada

    Published in Swissreg on 01.09.2024

  5. 01-09-2023

    Midada

    Published in Swissreg on 01.09.2023

  6. 01-09-2022

    Midada

    Published in Swissreg on 01.09.2022

  7. 10-08-2022

    Midada

    Published in Swissreg on 10.08.2022

  8. 27-12-2021

    Represchentant inscrit

    Representative
    AWA Switzerland Ltd., Case Postale 2243, 2800 Delémont 2

    Published in Swissreg on 27.12.2021

1 endataziun pli veglia
  1. 29-09-2021

    Concedì

    Published in Swissreg on 29.09.2021

Partidas

Possessur

GlaxoSmithKline Intellectual Property Development Limited

GSK Medicines Research Centre Gunnels Wood Road, Stevenage, SG1 2NY, GB

BioVersys AG

Bioversys AG

Technologiepark Basel Hochbergerstrasse 60c, 4057 Basel

Represchentant

AWA Switzerland SA

AWA Switzerland Ltd.

Case Postale 2243, 2800 Delémont 2

Inventur

DEPREZ, Benoit

59000 Lille, FR

REMUIÑAN-BLANCO, Modesto Jesús

28760 Madrid, ES

WILLAND, Nicolas

59000 Lille, FR

PORRAS DE FRANCISCO, Esther

28760 Madrid, ES

BOUROTTE, Marilyne

59840 Perenchies, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.